Amicus Therapeutics, Inc. (FOLD)
14.34
+0.01
(+0.07%)
USD |
NASDAQ |
Mar 06, 16:00
14.43
+0.09
(+0.63%)
After-Hours: 20:00
Amicus Therapeutics SG&A Expense (TTM) : 383.49M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| BioMarin Pharmaceutical, Inc. | 1.153B |
| CorMedix, Inc. | 60.19M |
| Krystal Biotech, Inc. | 146.91M |
| MannKind Corp. | 229.86M |
| Keros Therapeutics, Inc. | 35.11M |